Teijin Company Description
Teijin Limited engages in the fibers, films and sheets, composites, healthcare, and IT businesses worldwide.
It offers aramid fibers; glass and carbon fibers, composite materials, and oxidized PAN fibers; polycarbonate sheets and films; high-density polyethylene porous films and materials; and microporous films.
The company also provides PC resins, polyphenylene sulfide resins, molded parts, and additives; lightweight glass and carbon fiber reinforced composites for automotive applications; and polytrimethylene telephthalate products, artificial leather materials, polyester nanofibers, and recycled polyester fibers.
In addition, it offers pharmaceuticals for bone and joint, respiratory, cardiovascular and metabolic, and other diseases; home oxygen therapy, non-invasive positive pressure ventilation, and sleep disordered breathing related devices, as well as sonic accelerated fracture healing system and community-based integrated care system businesses.
Further, the company provides implantable medical devices and regenerative medical products. Additionally, it develops and implements engineering solutions for various issues, such as environmental pollution, energy supply stability, and aging-related workforce population decline.
Teijin Limited was incorporated in 1918 and is headquartered in Tokyo, Japan.

Country | Japan |
Founded | 1918 |
Industry | Conglomerates |
Sector | Industrials |
Employees | 20,279 |
CEO | Akimoto Uchikawa |
Contact Details
Address: Kasumigaseki Common Gate West Tower Tokyo, 100-8585 Japan | |
Phone | 81 3 3506 4529 |
Website | teijin.com |
Stock Details
Ticker Symbol | TINLY |
Exchange | OTCMKTS |
Fiscal Year | April - March |
Reporting Currency | JPY |
ISIN Number | US8790632041 |
SIC Code | 2820 |
Key Executives
Name | Position |
---|---|
Akimoto Uchikawa | President, Chief Executive Officer and Representative Director |
Naohiko Moriyama | Senior Managing Executive Officer, Chief Financial Officer and Representative Director |
Tsutomu Morioka | Chief Information Officer |
Naoki Hamashima | General Manager of Investor and Public Relations Department |
Akihiko Uchiyama | Chief Officer (Legal, Intellectual Property) and GM of Intellectual Property Department |
Arao Kentaro | Chief Marketing Officer and General Manager of New Business Development Business Unit |
Fumiaki Sakurai | Group Executive Officer and Chief Human Resources and Sustainability Officer |
Hiroshi Uno D.V.M., Ph.D. | Senior ExecutiveOfficer, GM and President of Healthcare Business Group |
Tamotsu Koyama | Deputy Chief Social Responsibility Officer and Executive Staff of Technology |
Tsunehiro Ogawa | Chief Officer of Special Project, Senior Corporate Project Officer and Teijin Group Executive Officer |